Role of Scar‐Associated Macrophages in Organ Fibrosis Diseases
Journal of Immunology Research · 2026
DOI: 10.1155/jimr/8393673 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Immunology Research, 2026. Verfasst von Runmin Ding und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Jiangsu Key Laboratory of Urological Disease Prevention and Treatment, The Second Affiliated Hospital of Nanjing Medical Unive…. Hauptthemen laut MEDLINE: Macrophages, Cicatrix. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Support Program of Jiangsu Province, Jiangsu Province Natural Science Foundation Program.
Abstract (Originalsprache)
Fibrosis refers to the scarring and hardening of tissue resulting from the excessive deposition of extracellular matrix (ECM) proteins by myofibroblasts during chronic inflammatory responses, which can ultimately lead to organ failure and potentially death. Different states of macrophage activation are critical in regulating both the progression and regression of fibrosis. However, the conventional M1/M2 polarization model fails to accurately capture the dynamic and heterogeneous states of macrophages observed in vivo. As a result, an increasing number of studies have begun to classify macrophages based on their functional phenotypes. One specific subset of functionally distinct macrophages, termed scar‐associated macrophages (SAMs), has been confirmed to play a significant regulatory role in organ fibrosis. This review provides a comprehensive summary of recent advances in understanding the role of SAMs in fibrotic diseases across multiple organs, including the liver, lungs, heart, and kidneys. It further explores the emerging conceptual framework of hot and cold fibrosis, highlighting the potential role of SAMs as central cellular mediators that sustain a positive feedback loop between inflammation and fibrosis in the “hot fibrosis” state. Building on these insights, this review also discusses future research directions aimed at developing targeted therapeutic strategies to modulate SAM activity and mitigate fibrosis in diverse organ systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Jiangsu Key Laboratory of Urological Disease Prevention and Treatment, The Second Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, China, njmu.edu.cn.
- The Second Clinical Medical College, Nanjing Medical University, Nanjing, China, njmu.edu.cn.
- Department of Urology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China, njmu.edu.cn.
- The First Clinical Medical College, Nanjing Medical University, Nanjing, China, njmu.edu.cn.
ORCID-Profile: Runmin Ding, Zexin Yang, Yuxi Chen, Qiqin Yu, Yisheng Ji, Zijie Wang, Min Gu
Förderung
- National Natural Science Foundation of China
- Science and Technology Support Program of Jiangsu Province
- Jiangsu Province Natural Science Foundation Program
- Postgraduate Research & Practice Innovation Program of Jiangsu Province
Zitieren
APA
Ding, R., Yang, Z., Chen, Y., Yu, Q., Ji, Y., Wang, Z., & Gu, M. (2026). Role of Scar‐Associated Macrophages in Organ Fibrosis Diseases. Journal of Immunology Research. https://doi.org/10.1155/jimr/8393673
Vancouver
Ding R, Yang Z, Chen Y, Yu Q, Ji Y, Wang Z, et al. Role of Scar‐Associated Macrophages in Organ Fibrosis Diseases. Journal of Immunology Research. 2026. doi:10.1155/jimr/8393673
BibTeX
@article{Ding2026,
author = {Ding, Runmin and Yang, Zexin and Chen, Yuxi and Yu, Qiqin and Ji, Yisheng and Wang, Zijie and Gu, Min},
title = {Role of Scar‐Associated Macrophages in Organ Fibrosis Diseases},
journal = {Journal of Immunology Research},
year = {2026},
doi = {10.1155/jimr/8393673}
}
EUVIMED